FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to using a purine derivatives for preparing drug preparations for treating chronic lymphocytic leukaemia and polycystic kidneys.
EFFECT: invention provides preparing the compounds possessing higher activity on lymphocytic leukaemia and polycystic kidneys.
8 cl, 3 dwg, 1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PERHARIDINES AS CDK INIHIBITORS | 2008 |
|
RU2498984C2 |
| 6,9-DISUBSTITUTED 2-[TRANS-(4-AMINOCYCLOHEXYL)-AMINO]PURINES | 1999 |
|
RU2191777C2 |
| COMPOUNDS APPLICABLE FOR TREATING AIDS | 2010 |
|
RU2575845C2 |
| COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES | 2014 |
|
RU2681943C9 |
| COMPOUNDS APPLICABLE FOR TREATING PREMATURE AGEING AND PARTICULARLY PROGERIA | 2010 |
|
RU2575646C2 |
| PYRIMIDINE-SUBSTITUTED PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD OF PROTEIN KINASE INHIBITION, METHOD OF TREATING OR PREVENTING DISEASES SENSITIVE TO PROTEIN KINASE INHIBITION AND METHOD OF TREATING PROLIFERATIVE DISEASES | 2008 |
|
RU2518098C2 |
| COMPOUNDS SUITABLE FOR CANCER TREATMENT | 2010 |
|
RU2567752C2 |
| NEW QUINAZOLIONIC DERIVATIVES INHIBITING PI3K, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2017 |
|
RU2702904C1 |
| PHARMACEUTICAL COMPOSITIONS ABLE TO INDUCE CANCER CELL APOPTOSIS FOR DIAGNOSING AND TREATING B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA | 2007 |
|
RU2454245C2 |
| CYCLIC C-TERMINAL PEPTIDE OF ACETYLCHOLINESTERASE IN TREATING OR PREVENTING CANCER OR METASTASIS | 2015 |
|
RU2711161C2 |
